| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Research and development | 2,367 | 1,593 | ||
| General and administrative | 5,167 | 1,828 | ||
| Total operating expenses | 7,534 | 3,421 | ||
| Loss from operations | -7,534 | -3,421 | ||
| Interest expense | 0 | 0 | ||
| Interest income | 83 | 84 | ||
| Total other income, net | 83 | 84 | ||
| Loss before income taxes | -7,451 | -3,337 | ||
| Income taxes | 0 | 0 | ||
| Net loss | -7,451 | -3,300 | ||
| Loss per share - basic and diluted (in dollars per share) | -1.38 | -1.07 | ||
| Weighted average shares outstanding - basic and diluted (in shares) | 5,411,709 | 3,105,156 | ||
Autonomix Medical, Inc. (AMIX)
Autonomix Medical, Inc. (AMIX)